The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Forward Dividend Yield %: 2.01% (As of Jun. 28, 2026)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
20 GF Score
Price BDT320.20
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Forward Dividend Yield %?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.63% 20 Forward Dividend Yield % is 2.01% as of Jun. 28, 2026. GuruFocus rates DHA:IBNSINA with a GF Score™ of 20/100. Among 505 Drug Manufacturers companies, The IBN SINA Pharmaceutical Industry ranks worse than 52.67% on this metric.

As of today (2026-06-28), the Forward Annual Dividend Yield of The IBN SINA Pharmaceutical Industry is 2.01%.

As of today (2026-06-28), the Trailing Annual Dividend Yield of The IBN SINA Pharmaceutical Industry is 2.01%.

DHA:IBNSINA's Forward Dividend Yield % is ranked worse than
52.67% of 505 companies
in the Drug Manufacturers industry
Industry Median: 2.14 vs DHA:IBNSINA: 2.01

The IBN SINA Pharmaceutical Industry's Dividends per Share for the six months ended in . 20 was BDT0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


The IBN SINA Pharmaceutical Industry Forward Dividend Yield % Related Terms


DHA:IBNSINA vs IMNPQ: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The IBN SINA Pharmaceutical Industry Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's Forward Dividend Yield % falls into.


DHA:IBNSINA
20GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

The IBN SINA Pharmaceutical Industry Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
BDT 6.4000002025-10-272025-10-262026-01-01Cash DividendannuallyBDT:BDT 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

The IBN SINA Pharmaceutical Industry's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=6.4/320.20
=2.00 %

Current Share Price is BDT320.20.
The IBN SINA Pharmaceutical Industry's Dividends per Share for the forward twelve months is calculated as BDT6.4 * 1 = BDT6.4.

The IBN SINA Pharmaceutical Industry's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=6.4/320.20
=2.00 %

Current Share Price is BDT320.20.
The IBN SINA Pharmaceutical Industry's Dividends per Share for the trailing twelve months (TTM) ended in Today is BDT6.4.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 2.01% mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Forward Dividend Yield % of 2.01% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. According to the industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #266 out of 505 companies in the Drug Manufacturers industry, placing it in the top 52.7%.
Is The IBN SINA Pharmaceutical Industry's Forward Dividend Yield % too high?
The IBN SINA Pharmaceutical Industry's current Forward Dividend Yield % is 2.01%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.14. The IBN SINA Pharmaceutical Industry's value of 2.01% is 6.1% below this industry median. Based on the distribution chart, The IBN SINA Pharmaceutical Industry ranks #266 out of 505 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Forward Dividend Yield % compare to IMNPQ?
According to the Drug Manufacturers industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #266 out of 505 companies for Forward Dividend Yield %. This places The IBN SINA Pharmaceutical Industry in the lower half of its industry. The industry median Forward Dividend Yield % is 2.14. The IBN SINA Pharmaceutical Industry's value of 2.01% is 6.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.14, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The IBN SINA Pharmaceutical Industry's current Forward Dividend Yield % of 2.01% is 6.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The IBN SINA Pharmaceutical Industry's current Forward Dividend Yield % is 2.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Forward Dividend Yield % of 2.01%. The current Forward Dividend Yield % is 2.01% and 6.1% below the Drug Manufacturers industry median of 2.14. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Forward Dividend Yield % is 2.01% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score

Get the complete analysis for DHA:IBNSINA

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT320.20
Price